Eddie Sullivan, PHD
Eddie Sullivan, PhD, SAb Biotherapeutics
Dr. Sullivan is the president and CEO of Sab Biotherapeutics, a company that produced the world’s first large animals species that produces fully human polyclonal antibodies. He has been a thought leader in this field and worked with various committees and discussion groups that have focused on animal biotechnology and has actively participated in discussions for establishing a regulatory framework for genetically engineering animals.
Topic: The Use of Genetically Engineered Large Animals to Rapidly Respond to Emerging Infectious Disease Through the Production of Therapeutic Antibodies